KERALAYUR.BO

Kerala Ayurveda Limited
BSEINREQUITY Healthcare DELAYED
Last price
189.05
▼ 9.90 (4.98%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
196.00
Prev close
198.95
Day high
196.00
Day low
189.05
Volume
42.82K
Market cap
$2.46B
P/E (TTM)
52W range
145.00 – 506.85

Day trading desk

Current session · delayed
Gap from prior close
-1.48%
Prior close 198.95
VWAP
189.99
-0.50% from price
Relative volume
1.78×
Unusually busy
Session range
3.68%
189.05 – 196.00
Position in range
0%
Near session low
ATR (14D)
12.23
6.47% of price
Prior day high
214.40
PDH
Prior day low
196.65
PDL
Bid / ask spread
Quote not published
Session volume
42.25K
Avg 23.79K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+17.71% +19.1%
1M
+21.03% +17.3%
3M
-8.45% -11.5%
6M
-18.37% -29.4%
YTD
-40.13% -52.4%
1Y
-63.45% -83.4%
3Y
+68.12% -6.1%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on KERALAYUR.BO open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
7.60M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 4, 25
Katra Phytochem India, Pvt. Ltd.
Institution- Corporation
200.00K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

1 reporting
NameRelationShares heldLatest
Katra Phytochem India, Pvt. Ltd.
Institution- Corporation 324.40K Sale

Fundamentals

TTM · reported
Market cap$2.46B
Enterprise value$3.26B
Revenue (TTM)$1.36B
Gross profit$1.11B
EBITDA$-167.69M
Net income$-265.23M
EPS (TTM)$-21.68
Free cash flow
Total cash$57.51M
Total debt$864.75M
Book value / share$8.35
Shares outstanding13.00M
Float5.74M
Short % of float
Dividend yield
Beta (5Y)0.35

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book22.63
EV / revenue2.40
EV / EBITDA-19.45
Gross margin81.73%
Operating margin-17.18%
Profit margin-19.54%
Return on equity
Return on assets
Debt / equity580.80
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 5 quarters
Blank means not reported, not zero
Line item20262025202420232022YoY
Total revenue $1.31B$1.20B$1.03B$930.47M +9.0%
Operating revenue $1.31B$1.20B$1.03B$930.47M +9.0%
Cost of revenue $275.85M$226.90M$251.97M$227.58M +21.6%
Gross profit $1.04B$976.42M$775.97M$702.89M +6.1%
Research & development $1.26M$1.52M$3.62M$1.16M
Selling, general & admin $343.34M$234.57M$168.90M$121.99M
Total operating expense $1.27B$1.08B$712.06M$652.82M +17.8%
Operating income -$232.36M-$99.68M$63.91M$50.07M -133.1%
Net interest income -$73.40M-$40.87M-$58.93M-$51.17M -79.6%
Pre-tax income -$163.64M-$122.36M$6.56M-$5.59M -33.7%
Tax provision -$397.00K$17.23M$12.16M-$1.31M -102.3%
Net income -$165.57M-$146.99M-$5.60M-$9.01M -12.6%
Net income to common -$165.57M-$146.99M-$5.60M-$9.01M -12.6%
Basic EPS -13.53-12.79-0.51-0.85 -5.8%
Diluted EPS -13.53-12.79-0.51-0.85 -5.8%
EBIT -$90.25M-$81.49M$53.13M$42.63M -10.7%
EBITDA -$35.39M-$31.74M$74.54M$53.70M -11.5%
Basic shares 12.24M11.49M10.91M10.56M +6.5%
Diluted shares 12.24M11.49M10.91M10.56M +6.5%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year $0
Next year $0

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders59.43%
Held by institutions0.00%
Institutions holding0
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
174.06
+8.61% from price
SMA 20
164.39
+15.00% from price
SMA 50
170.89
+10.62% from price
SMA 100
190.74
-0.89% from price
SMA 200
237.98
-20.56% from price
EMA 12
176.91
+6.86% from price
EMA 26
170.62
+10.80% from price
EMA 50
173.73
+8.82% from price
RSI (14)
61.8
Neutral
MACD (12,26,9)
6.29
Hist 5.57
ATR (14)
12.23
6.47% of price
Realised vol 30D
56.3%
Annualised
Bollinger upper
197.52
20, 2σ
Bollinger lower
131.26
20, 2σ
50 / 200 cross
Death
170.89 vs 237.98
Trend bias
Below 200
-20.56%

Options chain

Account required
ExpirySpot 189.05
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.23
Less volatile than market
Correlation to SPY
0.05
Largely independent
Realised vol 30D
56.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-71.1%
Peak to trough
Max drawdown 5Y
-75.3%
Peak to trough
ATR 14
12.23
6.47% of price
Beta (reported)
0.35
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.